U.S. FDA Approves Nova Mentis Orphan Drug Application

Go back to U.S. FDA Approves Nova Mentis Orphan Drug Application
(AMEX: NMLSF) Delayed: 0.07 +0.03 (75.00%)
Previous Close $0.04    52 Week High
Open $0.04    52 Week Low
Day High $0.07    P/E N/A 
Day Low $0.04    EPS
Volume 1,500       

NovaMed, Inc. (NYSE: NOVA) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $13.31 
Open $0.22    52 Week Low $3.04 
Day High $0.22    P/E 0.24 
Day Low $0.22    EPS $0.92 
Volume 13